Uniting Innovation, Law, and Strategy in RNA, Cell and Gene Therapy, and Regenerative Medicines
Join the brightest minds in RNA, cell and gene therapies, and regenerative medicine at ACI’s 3rd Annual Forum on Advanced Therapeutics.
This premier event brings together industry leaders to explore evolving market trends, regulatory frameworks, and IP strategies shaping the future of advanced therapeutics. From funding innovations and AI in drug discovery to navigating legal and compliance challenges, gain the insights you need to drive scientific advancements to global market success.
2025 CONFERENCE CHAIRS
Derek Johnson
Managing Director and General Counsel
Portal Innovations
Lulu Wang
Head of IP
Orna Therapeutics
2025 FDA Keynote Speaker
Julie Tierney
Deputy Center Director, Center for Biologics Evaluation and Research
FDA
USPTO Interview
Andrea Grossman
Legal Advisor
Office of Patent Legal Administration
USPTO
2025 Featured Speakers
Christina M. Hartman
Senior Director, Government Affairs
Orchard Therapeutics
Deirdre Parsons
VP Public Policy and Government Relations
Alnylam
Jocelyn Ram
IP Counsel
The Broad Institute of MIT
Chuck Sholtz
Vice President, Intellectual Property
Nutcracker Therapeutics
Laurence Shumway
Vice President, Intellectual Property Counsel
Flagship Pioneering
Olga Zimmerman
Director, Intellectual Property
Caribou Biosciences, Inc.
IN-HOUSE INSIGHTS FROM
- AdaptImmune
- Alnylam
- Beam Therapeutics
- Caribou Biosciences
- The Broad Institute of MIT
- Flagship Pioneering
- Novo Nordisk
- Nutcracker Therapeutics
- Orchard Therapeutics
CLE Accreditation
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation. Learn More
ABOUT THIS CONFERENCE
ACI’s Advanced Therapeutics Forum: Uniting Innovation, Law and Strategy in RNA, Cell and Gene Therapy, and Regenerative Medicines
American Conference Institute is pleased to present the 3rd Annual Forum on Advanced Therapeutics, where the brightest minds in RNA, cell and gene therapies, and regenerative medicine converge to shape the future of this rapidly evolving field.
Positioned at the critical juncture of innovation, commercialization, and compliance — this premier event is dedicated to unraveling the complex interplay of evolving market trends, dynamic regulatory frameworks, and critical intellectual property strategies.
Join us in Boston on March 19–20 in this collaborative endeavor to drive forward the most groundbreaking developments in advanced therapeutics, marrying scientific discovery with strategic business and legal acumen for global impact.
Attend to engage with leading industry thought leaders and legal pioneers who will illuminate the path from groundbreaking research to global market success. Here, we explore in-depth the nuances of funding methodologies, AI’s transformative role in drug discovery, and the intricacies of navigating the legal, regulatory and IP landscapes.